These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28715904)

  • 1. Considerations for optimal management of patients with pulmonary arterial hypertension: a multi-stakeholder roundtable discussion.
    Studer SM; Kingman M; Calo L; Cannon HE; Dunn JD; James T; Lewis SJ; Gilkin RJ; Pruett JA
    Am J Manag Care; 2017 May; 23(6 Suppl):S95-S104. PubMed ID: 28715904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Therapeutic Paradigms and Guidelines in the Management of Pulmonary Arterial Hypertension.
    Hill NS; Cawley MJ; Heggen-Peay CL
    J Manag Care Spec Pharm; 2016 Mar; 22(3 Suppl A):S3-21. PubMed ID: 27003666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Review of the Economic Burden of Pulmonary Arterial Hypertension.
    Gu S; Hu H; Dong H
    Pharmacoeconomics; 2016 Jun; 34(6):533-50. PubMed ID: 26714685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population.
    Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T
    Appl Health Econ Health Policy; 2011 Sep; 9(5):293-303. PubMed ID: 21875160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Observations on the Use of Riociguat in a Large, Metropolitan Pulmonary Arterial Hypertension/Chronic Thromboembolic Pulmonary Hypertension Treatment Center.
    Sulica R; Fenton R; Cefali F
    Cardiol Ther; 2015 Dec; 4(2):209-18. PubMed ID: 26411969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological treatment of HIV-associated pulmonary hypertension.
    Chinello P; Petrosillo N
    Expert Rev Clin Pharmacol; 2016; 9(5):715-25. PubMed ID: 26863919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted therapies in pulmonary arterial hypertension.
    Montani D; Chaumais MC; Guignabert C; Günther S; Girerd B; Jaïs X; Algalarrondo V; Price LC; Savale L; Sitbon O; Simonneau G; Humbert M
    Pharmacol Ther; 2014 Feb; 141(2):172-91. PubMed ID: 24134901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updated treatment algorithm of pulmonary arterial hypertension.
    Galiè N; Corris PA; Frost A; Girgis RE; Granton J; Jing ZC; Klepetko W; McGoon MD; McLaughlin VV; Preston IR; Rubin LJ; Sandoval J; Seeger W; Keogh A
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D60-72. PubMed ID: 24355643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and therapy of pulmonary arterial hypertension in Italy: results of the INCIPIT2 survey].
    Enea I; Roncon L; Azzarito M; Bongarzoni A; Casazza F; D'Agostino C; Favretto G; Rubboli A; Zonzin P
    G Ital Cardiol (Rome); 2014 Dec; 15(12):710-6. PubMed ID: 25533120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based pharmacologic management of pulmonary arterial hypertension.
    Benedict N; Seybert A; Mathier MA
    Clin Ther; 2007 Oct; 29(10):2134-53. PubMed ID: 18042471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment for pulmonary arterial hypertension-associated right ventricular dysfunction.
    Gomez-Arroyo J; Sandoval J; Simon MA; Dominguez-Cano E; Voelkel NF; Bogaard HJ
    Ann Am Thorac Soc; 2014 Sep; 11(7):1101-15. PubMed ID: 25079379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economic burden of chronic thromboembolic pulmonary hypertension in Russian Federation.
    Chazova IE; Martynyuk TV; Valieva ZS; Nakonechnikov SN; Nedogoda SV; Salasyuk AS; Taran IN; Gratsianskaya SE
    Ter Arkh; 2018 Sep; 90(9):101-109. PubMed ID: 30701743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel strategies for treatment of pulmonary arterial hypertension.
    Jasińska-Stroschein M; Orszulak-Michalak D
    Postepy Hig Med Dosw (Online); 2017 Jul; 71(0):577-588. PubMed ID: 28791952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of dyspnea in advanced pulmonary arterial hypertension.
    Sajkov D; Petrovsky N; Palange P
    Curr Opin Support Palliat Care; 2010 Jun; 4(2):76-84. PubMed ID: 20407377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment patterns and healthcare system burden of managed care patients with suspected pulmonary arterial hypertension in the United States.
    Copher R; Cerulli A; Watkins A; Laura Monsalvo M
    J Med Econ; 2012; 15(5):947-55. PubMed ID: 22554140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary arterial hypertension: progress and challenges in the modern treatment era.
    Mandras SA; Gilkin RJ; Pruett JA; Raspa S
    Am J Manag Care; 2014 Oct; 20(9 Suppl):S191-9. PubMed ID: 25495203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathways and Drugs in Pulmonary Arterial Hypertension - Focus on the Role of Endothelin Receptor Antagonists.
    Madonna R; Cocco N; De Caterina R
    Cardiovasc Drugs Ther; 2015; 29(5):469-79. PubMed ID: 26145170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary arterial hypertension: new insights into the optimal role of current and emerging prostacyclin therapies.
    Waxman AB; Zamanian RT
    Am J Cardiol; 2013 Mar; 111(5 Suppl):1A-16A; quiz 17A-19A. PubMed ID: 23414683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary arterial hypertension: a current review of pharmacological management.
    Sahni S; Ojrzanowski M; Majewski S; Talwar A
    Pneumonol Alergol Pol; 2016; 84(1):47-61. PubMed ID: 26693827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.
    Montani D; Chaumais MC; Savale L; Natali D; Price LC; Jaïs X; Humbert M; Simonneau G; Sitbon O
    Adv Ther; 2009 Sep; 26(9):813-25. PubMed ID: 19768639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.